Literature DB >> 8551972

Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis.

T Nohmi1, S Abe, K Dobashi, S Tansho, H Yamaguchi.   

Abstract

Sex steroid hormones were examined for their effect on mycelial growth of Candida albicans, and the inhibitory activity of casein-induced murine peritoneal neutrophils against mycelial growth of C. albicans was examined in vitro using a crystal violet staining method or a [3H]glucose incorporation method. Four steroid hormones, danazol, estradiol, estriol and testosterone had no effect on mycelial growth of C. albicans, but progesterone appeared to convert the growth form of C. albicans from hyphal to yeast. Danazol (10(-6) M) and progesterone (10(-5) M) suppressed anti-Candida activity of neutrophils of non-treated mice, while testosterone, estradiol, and estriol did not. The anti-Candida activity of neutrophils of estradiol-pretreated mice was clearly suppressed by progesterone even at 10(-6) M which corresponded to its plasma concentration in pregnant women in the third trimester. The physiological significance of this suppressive effect of progesterone was discussed in relation to the vulnerability of pregnant women to vaginal candidiasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551972     DOI: 10.1111/j.1348-0421.1995.tb02220.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  9 in total

1.  Effects of reproductive hormones on experimental vaginal candidiasis.

Authors:  P L Fidel; J Cutright; C Steele
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Influence of contraceptive choice on vaginal bacterial and fungal microflora.

Authors:  G Donders; G Bellen; D Janssens; B Van Bulck; P Hinoul; J Verguts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-09       Impact factor: 3.267

3.  Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.

Authors:  Amy E Gillgrass; Vera A Tang; Kate M Towarnicki; Kenneth L Rosenthal; Charu Kaushic
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 4.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.

Authors:  Amy E Gillgrass; Ali A Ashkar; Kenneth L Rosenthal; Charu Kaushic
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 7.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

Review 8.  Influence of ovarian hormones on urogenital infection.

Authors:  C Sonnex
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

9.  Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.

Authors:  Sayanika Devi Waikhom; Innocent Afeke; Grace Sefakor Kwawu; Hintermann Kobina Mbroh; George Yiadom Osei; Bengyella Louis; John Gameli Deku; Emmanuel Senyo Kasu; Prosper Mensah; Charles Yao Agede; Cornelius Dodoo; Emmanuel Akomanin Asiamah; John Tampuori; John Korbuvi; Japheth Awuletey Opintan
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-06       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.